search icon
      blog search icon

      BHC Stock Price History and Quote Analysis: Insights for Investors

      Bausch Health Companies Inc.

      (NYSE:BHC)

      $6.86

      -0.03 (-0.43%)

      At Close: 4:00 PM

      BHC Stock Price Graph

      • 1D
      • 5D
      • 1M
      • 3M
      • 6M
      • 1Y
      • YTD
      • All

      BHC Stock Price Today

      Bausch Health Companies Inc. (BHC) stock declined over -0.44% intraday to trade at $6.86 a share on NYSE. The stock opened with a loss of -2.90% at $6.69 and touched an intraday high of $6.70, falling -0.44% against the last close of $6.89. The Bausch Health Companies Inc. in stock market went to a low of $6.53 during the session.

      BHC Stock Snapshot

      $6.89

      Prev. Close

      2.51 Billion

      Market Cap

      $6.53

      Day Low

      $6.69

      Open

      N/A

      Number of Shares

      $6.70

      Day High

      N/A

      P/E ratio

      -2.65

      EPS (TTM)

      2.08

      Cash Flow per Share

      N/A

      Free Float in %

      -3.23

      Book Value

      1026378.00

      Volume

      BHC Stock Price History Chart

      DateOpenHighLowCloseVolume

      Contact Details

      2150 St. ElzEar Boulevard West
      Laval, QC H7L 4A8
      CA

      Website:https://www.bauschhealth.com

      Contact #:15147446792

      Company Information

      EmployeesN/A

      Beta0.95

      Sales or Revenue$8.54 Billion

      5Y Sales Change-1.32%

      Fiscal Year EndsDec. 2022

      SectorHealthcare

      IndustryDrug Manufacturers—Specialty & Generic

      About Company

      Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

      Peers

      Frequently Asked Questions

      icon

      What is the current Bausch Health Companies Inc. (BHC) stock price?

      Bausch Health Companies Inc. (NYSE: BHC) stock price is $6.86 in the last trading session. During the trading session, BHC stock reached the peak price of $6.70 while $6.53 was the lowest point it dropped to. The percentage change in BHC stock occurred in the recent session was -0.44% while the dollar amount for the price change in BHC stock was -$0.03.

      icon

      BHC's industry and sector of operation?

      The NYSE listed BHC is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector. Bausch Health Companies Inc. , together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology.

      icon

      Who are the executives of BHC?

      Mr. Arthur J. Shannon
      Senior Vice President and Head of Investor Relations & Global Communications
      Mr. John S. Barresi
      Senior Vice President, Controller & Chief Accounting Officer
      Ms. Kathleen Fitzpatrick
      Senior Vice President & Chief HR Officer
      Ms. Seana Carson
      Executive Vice President & Gen. Counsel

      icon

      How BHC did perform over past 52-week?

      BHC's closing price is 0.48% higher than its 52-week low of $5.57 where as its distance from 52-week high of $10.23 is -0.68%.

      icon

      How many employees does BHC have?

      Number of BHC employees currently stands at N/A. BHC operates from 2150 St. ElzEar Boulevard West, Laval, QC H7L 4A8, CA.

      icon

      Link for BHC official website?

      Official Website of BHC is: https://www.bauschhealth.com

      icon

      How do I contact BHC?

      BHC could be contacted at phone #15147446792 and can also be accessed through its website. BHC operates from 2150 St. ElzEar Boulevard West, Laval, QC H7L 4A8, CA.

      icon

      How many shares of BHC are traded daily?

      BHC stock volume for the day was 1026378.00 shares. The average number of BHC shares traded daily for last 3 months was 2.84 Million.

      icon

      What is the market cap of BHC currently?

      The market value of BHC currently stands at $2.51 Billion with its latest stock price at $6.86 and N/A of its shares outstanding.